5th generation glp 1 Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements Nutritional priorities to support GLP-1

While indicated for managing type 2 diabetes, recent interest in its off-label use for obesity has surged

Journal of Medicine and Life, 9, 79-83

Additional information DISCLOSURE/CONFLICT OF INTEREST Michael Berk declares that over the past three years, he has received compensation from Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Norvatis, Mayne Pharma and Servier

Omega-3 fatty acids and inflammatory processes: From molecules to man

Mental Health: Mood screenings to address anxiety or depression linked to rapid weight loss